MTCH vs NKTR · P/E 13, rev $1.72B vs rev $21.0M
Match Group Inc (MTCH) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Match Group Inc (MTCH) is a internet content & information company listed on NASDAQ.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported MTCH revenue for 2026-06-30 was $1.72B. Net income was $337.4M. Revenue was up 98.7% from 2026-03-31 to 2026-06-30. MTCH currently screens at market cap $8.24B and trailing P/E 13.5.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
MTCH currently screens at market cap $8.24B and trailing P/E 13.5. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the MTCH and NKTR stock pages for the full models.
Not investment advice.